Plain-English translation of NCT07421713 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study evaluates a new artificial intelligence software called Osteo Signal that analyzes chest X-rays to detect osteoporosis risk in adults over 50. Researchers want to see if this AI tool works as well as the standard bone density scan (DXA scan) that doctors currently use. This is a retrospective study, meaning researchers will review medical images and records that people have already had taken—there is no new testing or procedures required from participants.
Osteoporosis is a silent disease where bones become weak and brittle, but many people don't get screened because bone density scans require a separate appointment. If this AI software can accurately detect bone loss from chest X-rays that people already have, it could help catch osteoporosis earlier and easier.
You likely qualify if…
You likely don't qualify if…
There is no active participation required. Researchers will access your existing chest X-rays and bone density scan results from your medical records to compare how well the AI software detects bone loss compared to the standard test. Your personal information will be kept confidential. This is entirely a review of records you've already had taken.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Netherlands
United Kingdom